![]()
- China: Low US Interest Rates Threaten Recovery
- Hedge Fund Billionaire Paulson Reports New Citi Stake
- White House Plans to Freeze Spending to Cut Deficit
- Cramer: 5 Earnings Reports to Watch Next Week
- Court Rejects 'Clawbacks' for Alleged Stanford Victims
- Cities With the Most Home Price Reductions
- Tax Credit Sparking First-Time Home Sales: Realtors
- Investors Cut Back US Stocks for Bigger Growth Abroad
- This Year's Biggest Thanksgiving Leftover: Cash
- U.S. Stocks Rally for the Second Straight Week
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
- First Time Buyers Rescue Housing: Realtors
- Dollar General Trades Higher After Its IPO
MOST SHARED
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- Today's Market Action
- CNBC TRANSCRIPT: Warren Buffett & Bill Gates - Keeping America Great
- Has Twitter's Finest Hours (Seconds) Come and Gone?
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- Israel Going Green
- China's Role as Lender Alters Dynamics for United States
- Inside Wal-Mart's Acai Berry Juice Maker
A first-of-its-kind study suggests that allergic reactions to the popular vaccine for cervical cancer are rare and can often be overcome.
Australian researchers report in the new issue of the "British Medical Journal" that hypersensitivity to the shots is uncommon and that most girls who do have a reaction can later go on to get the shots with no serious side effects. The doctors recommend that more studies be done, however.
Last year Australia started requiring adolescent schoolgirls to get the vaccine for the human papillomavirus (HPV), the sexually transmitted infection that is the leading cause of cervical cancer. After more than 380,000 doses were administered, 35 girls were identified as having had some kind of reaction. The problems included rash, hives and in two patients a more severe, widespread allergic response.
The BMJ study is being published close on the heels of a recent report out of the U.S. Centers for Disease Control that concluded there's no evidence that Gardasil has serious side effects.
Merck [MRK
Loading...
()
] sells the vaccine, Gardasil, in the United States. GlaxoSmithKline [GSK
Loading...
()
] is awaiting FDA approval on a similar product called Cervarix. The Australian researchers say the Merck shots may have ingredients that could be causing the small number of allergic reactions and that the GSK vaccine, which is made differently, could be an alternative for some girls.
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- For the chief of cable company Comcast, growth has been about making deals – generally very large deals.
- Some companies may start using insurance to shift carbon risk from their balance sheets to maybe... yours?
- The president and founder of Genesis Today wants to improve America’s health, and thinks Wal-Mart can help.
- Switzerland's privacy watchdog is taking legal action to force Google to make changes to its Street View service.
- A wealthy, distracted Texas driver crashed his million-dollar Bugatti Veyron sports car into a salt marsh, say police.














